No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹86.98Prev. Close
₹84.94Turnover(Lac.)
₹7.87Day's High
₹86.98Day's Low
₹8152 Week's High
₹122.4352 Week's Low
₹78.05Book Value
₹91.09Face Value
₹10Mkt Cap (₹ Cr.)
102.46P/E
7.82EPS
10.65Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 12.3 | 12.3 | 12.3 | 12.3 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 86.67 | 73.33 | 58.93 | 47.57 |
Net Worth | 98.97 | 85.63 | 71.23 | 59.87 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2017 |
|---|---|---|---|
Revenue | 60.75 | 55.84 | 48.76 |
yoy growth (%) | 8.77 | 14.52 | |
Raw materials | -21.87 | -23.65 | -21.06 |
As % of sales | 36.01 | 42.35 | 43.2 |
Employee costs | -3.97 | -4.11 | -3.18 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2017 |
|---|---|---|---|
Profit before tax | 12.74 | 5.99 | 3.26 |
Depreciation | -2.81 | -2.76 | -2.81 |
Tax paid | -3.11 | -1.22 | -1.51 |
Working capital | 14.37 | 10.27 | |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2017 |
|---|---|---|---|
Growth matrix (%) | |||
Revenue growth | 8.77 | 14.52 | |
Op profit growth | 69.47 | 10.59 | |
EBIT growth | 97.21 | 17.67 | |
Net profit growth | 143.67 | 171.62 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,891.3 | 103.97 | 4,53,750.23 | 705.44 | 0.85 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,858 | 70.79 | 1,82,116.76 | 598 | 0.44 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,469.2 | 67.75 | 1,51,313.88 | 577 | 0.13 | 2,547 | 249.82 |
Cipla Ltd CIPLA | 1,401.9 | 30.6 | 1,13,225.36 | 384.64 | 0.93 | 3,840.92 | 423.38 |
Dr Reddys Laboratories Ltd DRREDDY | 1,318.5 | 34.17 | 1,10,037 | -219.4 | 0.61 | 3,802.6 | 375.78 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director / M D / Promoter
FALGUN VALLABHBHAI SAVANI
Executive Director & CEO
JIGNESHBHAI VALLABHBHAI SAVANI
Independent Non Exe. Director
Krishna Mitulbhai Shah
Independent Non Exe. Director
Kajal Chintanbhai Vaghani
Independent Non Exe. Director
Pravin Manjibhai Bhayani
Independent Non Exe. Director
Bintal Bhaveshkumar Shah
Company Sec. & Compli. Officer
Sanket Bhupendrabhai Trivedi
805 Dwarkesh Complex,
RC Dutt Road Alkapuri,
Gujarat - 390007
Tel: 91-265-2332018
Website: http://www.pardrugs.com
Email: cs.sanket@pardrugs.com
5th Floor 506 to 508,
ABC-I Off C G Road, Navrangpura,
Ahmedabad-380009
Tel: 91-79-26465179
Website: https://in.mpms.mufg.com/
Email: ipo.team@linkintime.co.in
Summary
Par Drugs and Chemicals Limited was originally incorporated as a Private Limited Company with the name Par Drugs and Chemicals Private Limited at Bhavnagar, Gujarat on 26 February 1999. Subsequently, ...
Read More
Reports by Par Drugs & Chemicals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.